Management of pancreatic masses

Daniel Wolfson; Jamie S. Barkin; Suresh T. Chari; Jonathan E. Clain; Richard H. Bell; Nicholas Alexakis; John P. Neoptolemos

doi:10.1097/01.mpa.0000180613.07948.ca

Management of pancreatic masses

Daniel Wolfson, Jamie S. Barkin, Suresh T. Chari, Jonathan E. Clain, Richard H. Bell, Nicholas Alexakis, John P. Neoptolemos

Gastroenterology and Hepatology

Research output: Contribution to journal › Review article › peer-review

36 Scopus citations

Abstract

Dr. William M Steinberg: The 2 sides have been presented. We have read and relearned the differential diagnosis of pancreatic masses. Non-neoplastic masses caused by CP or AIP and certain neoplastic processes such as lymphoma do not require resection. However, percutaneous or EUS-guided biopsy is not perfectly sensitive and cannot always make the diagnosis. Would a negative biopsy prevent the need for surgery, which may not only be curative but palliative? Furthermore, biopsy carries a small but definite risk, which may retard or occasionally complicate subsequent surgery. The reader must make his or her own decision based on the accumulated wisdom presented and discussed in this Controversies section.

Original language	English (US)
Pages (from-to)	203-217
Number of pages	15
Journal	Pancreas
Volume	31
Issue number	3
DOIs	https://doi.org/10.1097/01.mpa.0000180613.07948.ca
State	Published - Oct 1 2005

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism
Hepatology
Endocrinology

Access to Document

10.1097/01.mpa.0000180613.07948.ca

Cite this

@article{123420f103464192972c4ed199f995cd,

title = "Management of pancreatic masses",

abstract = "Dr. William M Steinberg: The 2 sides have been presented. We have read and relearned the differential diagnosis of pancreatic masses. Non-neoplastic masses caused by CP or AIP and certain neoplastic processes such as lymphoma do not require resection. However, percutaneous or EUS-guided biopsy is not perfectly sensitive and cannot always make the diagnosis. Would a negative biopsy prevent the need for surgery, which may not only be curative but palliative? Furthermore, biopsy carries a small but definite risk, which may retard or occasionally complicate subsequent surgery. The reader must make his or her own decision based on the accumulated wisdom presented and discussed in this Controversies section.",

author = "Daniel Wolfson and Barkin, {Jamie S.} and Chari, {Suresh T.} and Clain, {Jonathan E.} and Bell, {Richard H.} and Nicholas Alexakis and Neoptolemos, {John P.}",

year = "2005",

month = oct,

day = "1",

doi = "10.1097/01.mpa.0000180613.07948.ca",

language = "English (US)",

volume = "31",

pages = "203--217",

journal = "Pancreas",

issn = "0885-3177",

publisher = "Lippincott Williams and Wilkins",

number = "3",

}

TY - JOUR

T1 - Management of pancreatic masses

AU - Wolfson, Daniel

AU - Barkin, Jamie S.

AU - Chari, Suresh T.

AU - Clain, Jonathan E.

AU - Bell, Richard H.

AU - Alexakis, Nicholas

AU - Neoptolemos, John P.

PY - 2005/10/1

Y1 - 2005/10/1

N2 - Dr. William M Steinberg: The 2 sides have been presented. We have read and relearned the differential diagnosis of pancreatic masses. Non-neoplastic masses caused by CP or AIP and certain neoplastic processes such as lymphoma do not require resection. However, percutaneous or EUS-guided biopsy is not perfectly sensitive and cannot always make the diagnosis. Would a negative biopsy prevent the need for surgery, which may not only be curative but palliative? Furthermore, biopsy carries a small but definite risk, which may retard or occasionally complicate subsequent surgery. The reader must make his or her own decision based on the accumulated wisdom presented and discussed in this Controversies section.

AB - Dr. William M Steinberg: The 2 sides have been presented. We have read and relearned the differential diagnosis of pancreatic masses. Non-neoplastic masses caused by CP or AIP and certain neoplastic processes such as lymphoma do not require resection. However, percutaneous or EUS-guided biopsy is not perfectly sensitive and cannot always make the diagnosis. Would a negative biopsy prevent the need for surgery, which may not only be curative but palliative? Furthermore, biopsy carries a small but definite risk, which may retard or occasionally complicate subsequent surgery. The reader must make his or her own decision based on the accumulated wisdom presented and discussed in this Controversies section.

UR - http://www.scopus.com/inward/record.url?scp=25844468203&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=25844468203&partnerID=8YFLogxK

U2 - 10.1097/01.mpa.0000180613.07948.ca

DO - 10.1097/01.mpa.0000180613.07948.ca

M3 - Review article

C2 - 16163050

AN - SCOPUS:25844468203

SN - 0885-3177

VL - 31

SP - 203

EP - 217

JO - Pancreas

JF - Pancreas

IS - 3

ER -

Management of pancreatic masses

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this